This study investigates the use of chemotherapy after surgery in patients with high-risk pancreatic neuroendocrine tumors. The purpose of this study is to explore whether chemotherapy can prevent or delay the return of cancer in these patients.
The study evaluates the safety and effectiveness of chemotherapy in comparison to observation only. It looks at how well patients do without disease recurrence and overall survival.
- Who can participate: Adults aged 18 and older who have had surgery to remove a well-differentiated pancreatic neuroendocrine tumor may participate. Key eligibility factors include a specific Ki-67 test result and recovery from surgery.
- Study details: Participants will either receive chemotherapy or be monitored without active treatment. Chemotherapy involves taking oral medications. A placebo is not used in this study.
How understandable was the trial content above?
Hard to understand
Easy to understand